Result
€83,345 ▲ 214%
The result rose in 2025 from €26,555 to €83,345.
APKPHARMA
Lifetime
2 annual accounts with figures on one time axispeak €149,811 (2025)
€149,811▲ 182%
peak €83,345 (2025)
€83,345▲ 214%
peak €112,899 (2025)
€112,899▲ 282%
€938,643▲ 11.1%
Board1 name since 2023
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €53,137 to €149,811Result from €26,555 to €83,345Equity from €29,555 to €112,899Investments €98,285Cash from €5,088 to €17,700
Key points
from the 2025 annual accountsDebts
€938,643 89% of the balance sheet
Financial debts 73%Suppliers 1%Taxes and wages 7%Other 19%
Of this, €253,668 falls due within a year.
Position in the sector
€83,345
Higher net result than 94% of companies in retail trade. Sector median €4,767 · 25,234 companies.
2025 accounts filed 31 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0800193382
Incorporation
Founding capital of €3,000 · Founder: (fondateur unique) · Appointment: (sole director) · published on 03-04-2023 · Gazette deed
First establishment
Landbouwstraat 53, Zaventem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| APKPHARMA Manage | €1.1m | €149,811 | 10.7% | - |
| PHARMA OZ Charleroi | €1.2m | €136,712 | 13.3% | - |
| APOTHEEK BROOTHAERTS Willebroek | €1.0m | €169,425 | 21.9% | - |
| PHARMACIE PENNINCK Mons | €0.8m | €178,479 | 8.7% | 0.1 |
| PHARMA OGZ SRL Brussels | €1.3m | €162,468 | 7.0% | 1.8 |
| Prieels Pharma Oud-Heverlee | €1.3m | €129,913 | 8.9% | - |
| Pharmacie Rosart-Humblet Floreffe | €0.9m | €197,472 | 2.9% | 1.6 |
These companies have the same main activity as APKPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €843,000 and €1.3m, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 30-03-2023Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Establishment unit
- 2.345.672.4101930 Zaventem, since 30-03-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 17-11-2025
Insights on APKPHARMA
APKPHARMA has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €112,899 and a net result of €83,345.
Its solvency ranks better than 30% of 25,263 sector peers (NACE 47, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APKPHARMA
- What is the company number of APKPHARMA?
- The company number of APKPHARMA is 0800.193.382. The VAT number is the same number with BE in front: BE 0800.193.382.
- Where is APKPHARMA based?
- The registered office is at Rue Dedobbeleer 6, 7170 Manage.Company details
- What does APKPHARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APKPHARMA?
- APKPHARMA is a private limited company (BV).
- When was APKPHARMA founded?
- APKPHARMA was founded on 30-03-2023.
- Is APKPHARMA still active?
- Yes, APKPHARMA is an active enterprise in the KBO register.
- What is the turnover of APKPHARMA?
- The turnover in financial year 2025 is ≈ €450,000. This figure is estimated from the gross margin of €149,811 and 31 comparable companies (NACE 477). It probably lies between €320,000 and €850,000.Financials
- Is APKPHARMA profitable?
- In financial year 2025, APKPHARMA made a profit of €83,345.
- Where can I find the annual accounts of APKPHARMA?
- APKPHARMA filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APKPHARMA due?
- APKPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.